The newly created lectureship will examine how metabolism and the immune system interact, while identifying mechanisms that could inform microbiome-based strategies to prevent and treat overweight and obesity.

A recent report has mentioned that eating ultra-processed food has a higher risk of cardiovascular disease and death. It also highlights the risks of obesity, diabetes, hypertension, and chronic kidney disease.

A new study has found that obesity may increase the risk of severe infections such as influenza, Covid-19, pneumonia, and gastrointestinal and urinary tract infections in people.

It’s not what’s on the outside that counts: deep “hidden” fat around organs and in the liver may silently injure arteries, according to a new McMaster-led study that redefines how we assess obesity and cardiovascular risk.

The authors of a recent paper have revealed that changing the consumption-driven nature of our food systems would significantly benefit public health and the climate.

A recent pilot study has revealed that liver screening at health clinics can prevent liver diseases. It shares that the best path for addressing liver disease is to identify the issue early on and make lifestyle changes accordingly.

A study shows that women who experience premature menopause before age 40 are at a 40 % higher risk of developing coronary heart diseases. It also found that premature menopause was three times more common among black women than white women.

A survey has revealed that more than 80 % of the respondents mentioned that the cost of groceries is important when choosing a weight-loss plan, but only 6 % said they will try a plant-based or vegan diet, which research shows is among the least expensive and most effective for losing weight and keeping it off.

A study from Cold Spring Harbor Laboratory highlights a new target in Alzheimer’s research: blocking the enzyme PTP1B restored learning and memory in mice by reactivating the brain’s own immune cells to clear amyloid plaques. The results open the door to combination therapies that could go beyond current plaque-focused treatments and slow disease progression.

Researchers at Helmholtz Munich and the Technical University of Munich have developed fast-RSOM, a non-invasive imaging technology that visualises the smallest blood vessels through the skin and can detect early signs of cardiovascular disease long before clinical symptoms appear.